Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: A 2-year longitudinal study

Endocrine

Volumn 41, Issue 2, 2012, Pages 320-326

  De Bellis, Annamaria ^a   Conzo, Giovanni ^a   Cennamo, Gilda ^b   Pane, Elena ^a   Bellastella, Giuseppe ^a   Colella, Caterina ^a   Dello Iacovo, Assunta ^a   Paglionico, Vanda Amoresano ^a   Sinisi, Antonio Agostino ^a   Wall, Jack R ^c   Bizzarro, Antonio ^a   Bellastella, Antonio ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

G2sAb; Graves' ophthalmopathy; Ocular parameters; Thyroidectomy; TRAb

Indexed keywords

RADIOACTIVE IODINE; THIAMAZOLE; THYROTROPIN RECEPTOR; THYROXINE;

ADULT; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIFFERENTIATED THYROID CANCER; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; ENDOCRINE OPHTHALMOPATHY; EUTHYROIDISM; EYE EXAMINATION; FEMALE; HISTOLOGY; HUMAN; HYPERTHYROIDISM; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID SURGERY; THYROIDECTOMY;

EID: 84862661946     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9559-x     Document Type: Article

References (29)

1. B.S. Prabhakar, R.S. Bahn, T.J. Smith, Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr. Rev. 24, 802-835 (2003) (Pubitemid 38067700)
2. L. Bartalena, The dilemma of how to manage Graves' hyperthyrodism in patients with associated orbitopathy. J. Clin. Endocrinol. Metab. 96, 592-599 (2011)
3. R.S. Bahn, A.E. Heufelder, Pathogenesis of Graves'ophthalmopathy. New Engl. J. Med. 329, 1468-1475 (1993)
4. A. Feliciello, A. Porcellini, I. Ciullo, G. Bonavolontà, E.V. Avvedimento, G. Fenzi, Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 342, 337-338 (1993) (Pubitemid 23227563)
5. I.M. Wakelkamp, O. Bakker, L. Baldeschi, W.M. Wiersinga, M.F. Prummel, TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin. Endocrinol. 58, 280-287 (2003) (Pubitemid 36308115)
6. K. Gunji, A. De Bellis, A. Wu Li, M. Yamada, S. Kubota, B. Ackrell, S. Wengrowicz, A. Bellastella, A. Bizzarro, A. Sinisi, J.R. Wall, Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism. J. Clin. Endocrinol. Metab. 85, 1641-1647 (2000) (Pubitemid 32289512)
7. M. Kaspar, C. Archibald, A. De Bellis, A. Wu Li, M. Yamada, C. Chang, G. Kahaly, J.R. Wall, Eye muscle antibodies and subtype of thyroid-associated ophthalmopathy. Thyroid 12, 187-191 (2002) (Pubitemid 34259797)
8. T. Mizokami, M. Salvi, J.R. Wall, Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon? J. Endocrinol. Invest. 27, 221-229 (2004) (Pubitemid 38607474)
9. L. Bartalena, A. Pinchera, C. Marcocci, Management of Graves' ophthalmopathy: reality and perspectives. Endocr. Rev. 21, 168-199 (2000) (Pubitemid 32275594)
10. G.J. Kahaly, O. Shimony, Y.N. Gellman, S.D. Lytton, L. Eshkar-Sebban, N. Rosenblum, E. Refaeli, S. Kassem, J. Ilany, D. Naor, Regulatory T-Cells in graves' orbitopathy: baseline findings and immunomodulation by Anti-T lymphocyte globulin. J. Clin. Endocrinol. Metab. 96, 422-429 (2011)
11. N.A. Patwardhan, M. Moront, S. Rao, S. Rossi, L.E. Braverman, Surgery still has a role in Graves' hyperthyroidism. Surgery 114, 1108-1113 (1993) (Pubitemid 24004731)
12. M.S. Barakate, G. Agarwal, T.S. Reeve, B. Barraclough, B. Robinson, L.W. Delbridge, Total thyroidectomy is now the preferred option for the surgical management of Graves' disease. ANZ J. Surg. 72, 321-324 (2002) (Pubitemid 34535382)
13. L. Bartalena, M.L. Tanda, E. Piantanida, A. Lai, A. Pinchera, Relationship between management of hyperthyroidism and course of the ophthalmopathy. J. Endocrinol. Invest. 27, 288-294 (2004) (Pubitemid 38607483)
14. R.D. Bliss, P.G. Gauger, L.W. Delbridge, Surgeon's approach to the thyroid gland: surgical anatomy and the importance of technique. World J. Surg. 24, 891-897 (2000) (Pubitemid 30461209)
15. S.H. Acharya, A. Avenell, S. Philip, J. Burt, J.S. Bevan, P. Abraham, Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophtalmopathy: a systematic review. Clin. Endocrinol. 69, 693-950 (2008)
16. A. Pinchera, W. Wiersinga, D. Glinoer, P. Kendall-Taylor, L. Koornneef, C. Marcocci, H. Schleusener, J. Romaldini, H. Niepominiscze, S. Nagataki, M. Izumi, Y. Inoue, J. Stockigt, J.R. Wall, F. Greenspan, D. Solomon, J. Garrity, C.A. Gorman, Classification of eye changes of Graves' disease. Thyroid 2, 235-236 (1992)
17. M.F. Prummel, A. Bakker, W.M. Wiersinga, L. Baldeschi, M.P. Mourits, P. Kendall-Taylor, P. Perros, C. Neoh, A.J. Dickinson, J.H. Lazarus, C.M. Lane, A.E. Heufelder, G.J. Kahaly, S. Pitz, J. Orgiazzi, A. Hullo, A. Pinchera, C. Marcocci, M.S. Sartini, R. Rocchi, M. Nardi, G.E. Krassas, A. Halkias, Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European group on Graves' orbitopathy experience. Eur. J. Endocrinol. 48, 491-495 (2003) (Pubitemid 36622154)
18. L. Bartalena, L. Baldeschi, A.J. Dickinson, A. Eckstein, P. Kendall-Taylor, C. Marcocci, M.P. Mourits, P. Perros, K. Boboridis, A. Boschi, N. Currò, C. Daumerie, G.J. Kahaly, G. Krassas, C.M. Lane, J.H. Lazarus, M. Marinò, M. Nardi, C. Neoh, J. Orgiazzi, S. Pearce, A. Pinchera, S. Pitz, M. Salvi, P. Sivelli, M. Stahl, G. von Arx, W.M. Wiersinga, Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid 18, 281-282 (2008)
19. M.P. Mourits, M.F. Prummel, W.M. Wiersinga, L. Koornneef, Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin. Endocrinol. 47, 9-14 (1997) (Pubitemid 27313981)
20. S. Costagliola, N.G. Morgenthaler, R. Hoermann, K. Badenhoop, J. Struck, D. Freitag, S. Poertl, W. Weglohner, J.M. Hollidt, B. Quadbeck, J.E. Dumont, P.M. Schumm-Draeger, A. Bergmann, K. Mann, G. Vassart, K.H. Usadel, Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J. Clin. Endocrinol. Metab. 84, 90-97 (1999) (Pubitemid 29036685)
21. B. Winsa, J. Rastad, G. Akerstrom, H. Johansson, K. Westermark, F.A. Karlsson, Retrospective evaluation of subtotal and total thyroidectomy in Graves' disease with and without endocrine ophthalmopathy. Eur. J. Endocrinol. 132, 406-412 (1995)
22. A.P. Weetman, B.J. Harrison, Ablative or non-ablative therapy for Graves' hyperthyroidism in patients with ophthalmopathy? J. Endocrinol. Invest. 21, 472-475 (1998) (Pubitemid 28439010)
23. L. Bartalena, C. Marcocci, A. Lai, M.L. Tanda, Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid? J. Endocrinol. Invest. 31, 578-581 (2008)
24. C. Marcocci, G. Bruno-Bossio, L. Manetti, M.L. Tanda, P. Miccoli, P. Iacconi, M.P. Bartolomei, M. Nardi, A. Pinchera, L. Bartalena, The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study. Clin. Endocrinol. 51, 503-508 (1999) (Pubitemid 29513319)
25. M. Moleti, F. Mattina, I. Salamone, M.A. Violi, C. Nucera, S. Baldari, M.G. Lo Schiavo, C. Regalbuto, F. Trimarchi, F. Vermiglio, Effects of thyroidectomy alone or followed by radioiodine ablation of thyroid remnants on the outcome of Graves' ophthalmopathy. Thyroid 13, 653-658 (2003) (Pubitemid 36993561)
26. P. Perros, P. Kendall-Taylor, Natural history of thyroid eye disease. Thyroid 8, 423-425 (1998) (Pubitemid 28252426)
27. L. Bartalena, M.L. Tanda, Clinical practice. Graves' ophthalmopathy. N. Engl. J. Med. 360, 994-1001 (2009)
28. A. Antonelli, M. Rotondi, P. Fallahi, S.M. Ferrari, L. Barani, E. Ferranini, M. Serio, Increase of interferon-#-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. Clin. Endocrinol. 64, 189-195 (2006)
29. A. Antonelli, P. Fallahi, M. Rotondi, S.M. Ferrari, M. Serio, P. Miccoli, Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy. Br. J. Surg. 93, 1226-1231 (2006) (Pubitemid 44547021)